| scholarly article | Q13442814 |
| P50 | author | Diane Havlir | Q55950716 |
| Grant Dorsey | Q60029509 | ||
| Moses R Kamya | Q60043817 | ||
| Philip J Rosenthal | Q60060211 | ||
| P2093 | author name string | Jane Achan | |
| Liusheng Huang | |||
| Tamara D Clark | |||
| Abel Kakuru | |||
| Florence Mwangwa | |||
| Mary K Muhindo | |||
| Prasanna Jagannathan | |||
| Francesca T Aweeka | |||
| Victor Bigira | |||
| James Kapisi | |||
| Stephen Kinara | |||
| P2860 | cites work | Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy | Q43542964 |
| Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
| Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial | Q43947975 | ||
| HIV impact on mother and child mortality in rural Tanzania | Q43949365 | ||
| Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. | Q46564603 | ||
| T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV | Q57997592 | ||
| Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants | Q84819981 | ||
| Intermittent presumptive treatment for malaria | Q24809091 | ||
| Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial | Q28541598 | ||
| Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation | Q33293164 | ||
| Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children | Q33507089 | ||
| Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus | Q33817605 | ||
| Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial | Q34369756 | ||
| Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi | Q34452064 | ||
| A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa | Q34687538 | ||
| Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial | Q34748630 | ||
| Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants | Q35055212 | ||
| Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi | Q35452458 | ||
| Health outcomes of HIV-exposed uninfected African infants | Q35825690 | ||
| High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody | Q36055407 | ||
| Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria | Q37077284 | ||
| Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 | ||
| Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants | Q37555921 | ||
| Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials | Q37600130 | ||
| Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda | Q37725732 | ||
| Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial | Q37726083 | ||
| HIV-exposed uninfected children: a growing population with a vulnerable immune system? | Q38170189 | ||
| HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea | Q38868223 | ||
| Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children | Q38877477 | ||
| Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda | Q38879544 | ||
| Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study | Q38879589 | ||
| Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study | Q38882875 | ||
| Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants | Q39244633 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Uganda | Q1036 |
| malaria | Q12156 | ||
| prevention of HIV/AIDS | Q7242372 | ||
| malaria prevention | Q93598033 | ||
| P304 | page(s) | 2701-2709 | |
| P577 | publication date | 2014-11-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial | |
| P478 | volume | 28 |
| Q47602806 | Effect of Caregiver Training on the Neurodevelopment of HIV-Exposed Uninfected Children and Caregiver Mental Health: A Ugandan Cluster-Randomized Controlled Trial |
| Q38843857 | Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial |
| Q35097323 | Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens |
| Q35975609 | Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants |
| Q38850820 | Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women |
| Q91625196 | Intermittent preventive treatment for malaria in infants |
| Q91898654 | Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial |
| Q37350165 | Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting |
| Q36796860 | Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children |
| Q53683735 | Neruodevelopmental Outcomes in Pre-School Children Living with HIV-1 Subtypes A and D in Uganda. |
| Q35692524 | Poor housing construction associated with increased malaria incidence in a cohort of young Ugandan children |
| Q47258627 | Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz |
| Q36018444 | Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study |
| Q56352635 | Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis |
| Q37607325 | Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis |
| Q40097078 | Suboptimal Cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines |
| Q38850192 | The feasibility of an automated eye-tracking-modified Fagan test of memory for human faces in younger Ugandan HIV-exposed children |
| Q38850151 | The feasibility of automated eye tracking with the Early Childhood Vigilance Test of attention in younger HIV-exposed Ugandan children |
| Q99569237 | Treatment and prevention of malaria in children |
Search more.